PHARMARON BIOLOGICS (UK) LTD

Company number 04543737

Date	Type	Description	View / Download
26 Jan 2021	PSC07	Cessation of Allergan Plc as a person with significant control on 8 May 2020	(1 page)
26 Jan 2021	PSC02	Notification of Allergan Plc as a person with significant control on 31 May 2018	(2 pages)
26 Jan 2021	PSC07	Cessation of Eden Biopharma Group Limited as a person with significant control on 31 May 2018	(1 page)
26 Jan 2021	PSC07	Cessation of Agn Sundry Llc as a person with significant control on 1 April 2019	(1 page)
26 Jan 2021	SH01	Statement of capital following an allotment of shares on 27 November 2018 GBP 105	(3 pages)
26 Jan 2021	SH01	Statement of capital following an allotment of shares on 9 October 2018 GBP 104	(3 pages)
26 Jan 2021	SH01	Statement of capital following an allotment of shares on 9 October 2018 GBP 103	(3 pages)
19 Jan 2021	TM02	Termination of appointment of Judith Tomkins as a secretary on 2 October 2020	(1 page)
26 May 2020	CS01	Confirmation statement made on 20 May 2020 with no updates	(3 pages)
16 Sep 2019	AA	Full accounts made up to 31 December 2018	(30 pages)
20 May 2019	CS01	Confirmation statement made on 20 May 2019 with updates	(5 pages)
20 May 2019	PSC02	Notification of Agn Sundry Llc as a person with significant control on 1 April 2019	(2 pages)
06 Oct 2018	AA	Full accounts made up to 31 December 2017	(30 pages)
06 Jun 2018	CS01	Confirmation statement made on 31 May 2018 with updates	(5 pages)
23 May 2018	AP03	Appointment of Ms Judith Tomkins as a secretary on 19 February 2018	(2 pages)
23 May 2018	AP03	Appointment of Ms Patricia Maria Haran as a secretary on 19 February 2018	(2 pages)
18 Oct 2017	TM02	Termination of appointment of Tom Nelligan as a secretary on 13 October 2017	(1 page)
13 Oct 2017	TM01	Termination of appointment of Janice Elizabeth Stewart as a director on 30 June 2017	(1 page)
30 Sep 2017	AA	Full accounts made up to 31 December 2016	(30 pages)
09 Jun 2017	CS01	Confirmation statement made on 31 May 2017 with updates	(4 pages)
06 Oct 2016	CS01	Confirmation statement made on 24 September 2016 with updates	(5 pages)
23 Sep 2016	AA	Full accounts made up to 31 December 2015	(30 pages)
07 Jan 2016	CERTNM	Company name changed actavis biologics LIMITED\certificate issued on 07/01/16 NM01 ‐ Change of name by resolution RES15 ‐ Change company name resolution on 2016-01-06	(3 pages)
03 Nov 2015	AP03	Appointment of Mr Tom Nelligan as a secretary on 3 November 2015	(2 pages)
03 Nov 2015	TM01	Termination of appointment of David Adam Buchen as a director on 1 May 2015	(1 page)